Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
168,573,343
-
Share change
-
-1,834,483
-
Total reported value
-
$50,685,180,264
-
Put/Call ratio
-
122%
-
Price per share
-
$300.92
-
Number of holders
-
1,126
-
Value change
-
-$608,505,226
-
Number of buys
-
420
-
Number of sells
-
559
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q4 2018
As of 31 Dec 2018 BIOGEN INC. - COM (BIIB) had 1,126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 168,573,343 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Vanguard Group Inc, PRIMECAP MANAGEMENT CO/CA/, STATE STREET CORP, Clearbridge Investments, LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, AQR CAPITAL MANAGEMENT LLC, Invesco Ltd., and NORTHERN TRUST CORP.
This table shows 1,130 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.